C
CinRx Pharma
Developing novel therapeutics that address diverse therapeutic areas
About CinRx Pharma
CinRx is a biotechnology company that leverages its impressive industry experience to develop therapeutics in a novel way that meets the modern paradigm of drug development. The company operates in the pharmaceutical and biotech market, focusing on accelerating drug development programs to achieve marketing approval or facilitate a successful commercial exit. CinRx serves clients ranging from small biotech startups to large pharmaceutical companies, acting as both an operational and financial syndication partner. The business model revolves around providing comprehensive preclinical, clinical pharmacology, medical, biostatistical, and regulatory expertise. CinRx makes money through partnerships, clinical trial management, and successful exits of drug development programs. The company has a proven track record with 70 NDAs, 250 IND CTAs IMPDs, 36 patents, and 2,300 clinical trials.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Cincinnati, United States
- Employees
- 16
- Open positions
- None listed
- Dealroom signal
- 64.9/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, Woman Founder, DT and LS, science-based
- Business model
- Manufacturing
- Investment activity
- 3 companies, latest May 2024
- Capital deployed
- $202M
- Preferred round
- SERIES B
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | May 2024 | $73M | $292M | Undisclosed | ↗ |
| SERIES BOther financing | Nov 2017 | $10M | $40M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for CinRx Pharma is 80 monthly website visits, down 96.8% over the last three months. CinRx Pharma's team declined 11.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
CinDome PharmaCincinnati, United StatesInnovative treatment advancing care for chronic gastroparesis
$160Mvaluation
CinCor PharmaWaltham, United StatesClinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases
$1.8Bvaluation
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about CinRx Pharma on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See CinRx Pharma’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







